Serum disposition of sertraline, N-desmethylsertraline and paroxetine: a pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression

Human Psychopharmacology
Margareta ReisFinn Bengtsson

Abstract

Sertraline and paroxetine are frequently prescribed SSRIs for long-term treatment of major depression. Nevertheless, continuous follow-ups of drug concentrations prevailing in patients during the whole treatment period are not available. Hence, in a large phase IV clinical trial, a total of 353 patients with major depression were enrolled for a 6-month comparison of sertraline (50-150 mg daily) and paroxetine (20-60 mg daily). The present study reports the pharmacokinetic results of up to eight serum samples per patient. 1. A profound variability was found in the interindividual steady state and trough serum levels of sertraline, desmethylsertraline and paroxetine: the coefficient of variation (CV) was 59% for sertraline, 51% for desmethylsertraline, 27% for the ratio desmethylsertraline/sertraline (50 mg/day), and 71% for paroxetine (20 mg/day). The intraindividual CV for the ratio desmethylsertraline/sertraline was only 19%, indicating intraindividual metabolizing stability over time. Both sertraline and paroxetine displayed sex differences in the dose-concentration correlation. 2. It was possible to predict sertraline, but not paroxetine, steady state levels. 3. The terminal elimination t(1/2) for both drugs after 6 months o...Continue Reading

Citations

Dec 21, 2012·Journal of Neural Transmission·S UntereckerB Pfuhlmann
Jul 4, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Mikael LandénElias Eriksson
Jan 5, 2011·Expert Opinion on Drug Metabolism & Toxicology·Nikolaos KokrasZeta Papadopoulou-Daifoti
Dec 2, 2008·Expert Opinion on Drug Metabolism & Toxicology·Philip Gerretsen, Bruce G Pollock
Feb 3, 2016·International Journal of Clinical Pharmacy·Nazan Yuce-ArtunHalit Sinan Suzen
Mar 5, 2016·Psychoneuroendocrinology·Marnie G Silverstein-MetzlerThomas C Register
Mar 31, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Marianne Gex-FabryGilles Bertschy
Sep 6, 2006·Child and Adolescent Psychiatric Clinics of North America·David A Brent, Boris Birmaher
Jan 28, 2017·Journal of Affective Disorders·Michael PaulzenGeorgios Schoretsanitis
Apr 25, 2006·Journal of Clinical Psychopharmacology·Cüneyt Güzey, Olav Spigset
Dec 31, 2010·Journal of Clinical Psychopharmacology·Maria D ChermáPer A Gustafsson
Dec 19, 2019·Pharmacogenetics and Genomics·Rachel HuddartTeri E Klein
Oct 28, 2019·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Line S BråtenMarianne K Kringen
Jan 29, 2014·Psychosomatic Medicine·Leanne GrobanCarol A Shively
Aug 18, 2018·Archives of Women's Mental Health·Georgios SchoretsanitisMichael Paulzen
Jul 13, 2019·Current Opinion in Pharmacology·Yasmin SchmidSimon M Mueller
Mar 23, 2021·European Journal of Clinical Pharmacology·E HeinonenK Wide

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.